Exploration of Targeted Anti-tumor Therapy (eISSN 2692-3114), a peer-reviewed, open access online journal, publishes articles on all aspects of cancer research, including clinical diagnosis and analysis, case report, prevention, intervention treatment, pre-clinical and clinical trials of all types of cancers. Submissions with good originality, well-designed experiments and rigorous data are particularly welcomed.
Exploration of Targeted Anti-tumor Therapy is a bimonthly journal and published in February, April, June, August, October, December. All accepted articles will be published immediately after production. Readers can access the content as quickly as possible, and the paper can be cited immediately.
The journal provides immediate open access to all published content. Everyone can enjoy free and unrestricted use of these published content under the Creative Commons Attribution 4.0 International (CC BY) license. More information can be found at Open Access.
Scopus (Newly Accepted Mar. 2022)
All the articles of the journal are published under the CC BY license to further facilitate open access and improve the academic exchange among researchers. Under this license, authors retain the copyright and full publishing rights without restrictions, and they agree to make their original works completely available and free to use, copy and redistribute in all formats without permission as long as the authors and the original source are properly cited.
The journal adopts a single-blind peer review. Except for some Editorials released by the Editors, all manuscripts will undergo a strict review to assess their novelty, validity and significance, etc. More information can be found at Peer Review and Peer Review Guidelines. For the whole editorial process, please refer to Editorial Process.
To ensure long-term digital preservation, all the published articles will be archived on PubMed Central and Portico platform. Authors are also encouraged to deposit their articles in other appropriate funding body's archive.
The journal is owned and published by Open Exploration.